PGY-2 Oncology Pharmacy Residency

• 200+ oncology-based clinical trials
  • 60+ early phase oncology trials (precision cancer therapy program)
  • 110+ late phase oncology trials
  • 30+ pediatric oncology trials
• Medical Oncology sees approximately 9000 unique patients per year
• Hematology Oncology and Bone Marrow Transplant sees over 5000 unique patient per year
• Stem Cell Transplant Program:
  • Direct pediatric and adult patient care activities for autologous and allogenic stem cell transplants including matched-related, matched-unrelated, and haploidentical allogeneic stem cell transplants
  2019

  2020

  2021

  2022
  Pediatrics

  Autologous

  0

  0

  2

  0
  Allogeneic

  2

  1

  4

  2
  Adults

  Autologous

  44

  70

  71

  55
  Allogeneic

  13

  19

  10

  11
• Ochsner was the first in Louisiana to provide CAR T-cell Therapy commercially to patients. The oncology service line offers several different CAR T-cell products to our patients.
• Provider Teams
  • Hematology Oncology/BMT: 5 physicians, 8 nurse practitioners (4 inpatient, 4 outpatient), 3 transplant coordinators, quality manager, and data manager
  • Medical Oncology: 15 physicians and 8 nurse practitioners/physician assistants
  • Gynecologic Oncology: 6 physicians
  • Pediatric Oncology: 3 physicians and 1 nurse practitioner

• Forum
  • The resident(s) will alternate presenting weekly supportive care, drug class, or disease state discussions to enhance medication knowledge.
• Research
  • The resident(s) will be provided a list of research topics to choose from which they will develop a protocol, submit to the Institutional Review Board (IRB), collect data, present their research at a national meeting, and complete a publishable manuscript.
• Teaching and Education
  • The resident(s) will present a 60-minute formal continuing education (CE) presentation in the fall to the pharmacy department on an oncology-related topic of the resident’s choice
  • The resident(s) will present a 60-minute formal morbidity, mortality, and improvement (MM&I) presentation in the spring to the pharmacy department on an oncology-related pharmacy issue
  • The resident(s) will lead two APPE student topic discussions during the year focusing on oncology related supportive care, infectious disease, or drug information topics.
  • The resident(s) will complete two journal club presentations to the oncology clinical pharmacists during the residency year.
  • The resident(s) will submit two board-type questions based on the forum that resident presents that will be shared with the medical oncology fellows as part of their board question education series
• Drug Information
  • The resident(s) will serve as the Secretary for the System Oncology Subcommittee and provide minutes to pharmacy and oncology administration to report out at the System Pharmacy & Therapeutics Committee.
  • The resident(s) will complete a monograph or class review and present the recommendations to the System Oncology Subcommittee and any other committee as needed
  • The resident(s) will participate in a policy development or process improvement project or review and present the recommendations to the System Oncology Subcommittee and any other committee as needed
  • The resident(s) will complete a newsletter twice a year which is shared with clinical and infusion center pharmacists throughout the healthcare system. Submitted items include a summary of the resident’s journal club, drug information question write-up, and a safety corner update.
  • The resident(s) will complete a medication utilization evaluation (MUE) and present the findings to the System Oncology Subcommittee and any other committee as needed
• Staffing
  • The resident(s) will staff every 3rd weekend for a total of 17 weekends throughout the residency year. The resident(s) will also staff 1 major and 1 minor Ochsner observed holiday.
  • During the staffing rotation, the resident will act as the oncology unit-based clinical pharmacist and provide coverage to other areas as assigned.

• Comprehensive medical, dental, and vision insurance
• Health and Wellness Program
• Discounted gym membership
• 15 vacation days & 6 holidays

Application

The following materials should be submitted via the Pharmacy Online Residency Centralized Application System (PHORCAS) by the beginning of January

• Submit a letter of interest
• Three (3) letters of recommendation
• Curriculum Vitae (CV)

Deadline for completed applications is January 6^th, 2025

Eligibility

• Graduate of an accredited College/School of Pharmacy
• Eligible for licensure to practice pharmacy in the State of Louisiana
• Licensed in the State of Louisiana before the program begins or shortly thereafter
• Successful completion of a PGY-1 Pharmacy Practice Residency